Ex Vivo Phosphorus-31 Solid State Magnetic Resonance Spectroscopy Identifies Compositional Differences Between Bone...

Area of Science:

• Biomineralization
• Cardiovascular Research
• Materials Science

Background:

• Physiological bone mineralization and ectopic vascular calcification involve similar calcium phosphate minerals.
• Shared biological mechanisms may link bone mineral deposition and cardiovascular calcification.
• Understanding these mineral compositions is crucial for developing treatments for cardiovascular diseases.

Purpose of the Study:

• To compare the compositional features of calcium phosphates in bone and calcified vascular tissues.
• To utilize phosphorus-31 (³¹P) solid-state magnetic resonance (MR) spectroscopy for detailed compositional analysis.

Main Methods:

• Acquired ³¹P solid-state MR spectra from human trabecular bone, vascular plaque, and aortic valves, and from mouse aorta.
• Used synthetic hydroxyapatite and brushite as spectral models for phosphate (PO₄^-3) and hydrogen phosphate (HPO₄^-2) ions.
• Assessed spectral features and applied Herzfeld-Berger analysis to characterize mineral composition and maturity.

Main Results:

• Human specimens showed spectra consistent with mature, bone-like mineral, characterized by unprotonated phosphate (PO₄^-3), long CP time constants, and modest chemical shift anisotropy.
• Calcified mouse aorta exhibited spectral features indicative of immature, newly deposited mineral, including a prominent hydrogen phosphate (HPO₄^-2) component and short CP time constants.
• ³¹P solid-state MR spectroscopy successfully differentiated mineral compositions based on phosphate and hydrogen phosphate ion content.

Conclusions:

• ³¹P solid-state MR spectroscopy effectively distinguishes between mature and immature calcium phosphate mineral compositions in biological tissues.
• This technique offers valuable insights into pathological calcification processes in atherosclerosis and related disorders.
• It can serve as a complementary tool for basic research on cardiovascular calcific diseases.